http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer. http://medicalxpress.com/news/2012-11-success-therapy-common-non-small-cell.html Cancer Wed, 28 Nov 2012 13:35:43 EST news273332135 Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because of concerns for limited tolerance to toxic therapies. A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, says that fit elderly non-small cell lung cancer (NSCLC) patients should be considered for salvage targeted therapy. http://medicalxpress.com/news/2012-10-elderly-patients-therapy.html Cancer Mon, 15 Oct 2012 12:52:26 EST news269524333 A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, “many, many cancers could be manageable.” http://medicalxpress.com/news/2012-07-cancer-treatment-multidrug-strategy-emerges.html Cancer Wed, 11 Jul 2012 09:22:11 EST news261217281